{{knowledge objective
|Identifiant=OIC-075-31-B
|Item_parent=Smoking addiction
|Item_parent_short=Smoking addiction
|Rank=B
|Title=Knowing about medication other than nicotine replacement therapy
|Description=Varenicline and Bupropion
|Rubric=Management
|Contributors=
|Order=31}}
After nicotine replacement therapy, Varenicline can be offered as a second-line treatment, followed by Bupropion as a last-line treatment.

'''Varenicline''' :

* Partial agonist of nicotinic acetylcholine receptors.
* Indicated in cases of failure of nicotine replacement therapy and strong nicotine dependence.
* The main side effects are nausea, headaches, nightmares, insomnia, depression and cardiovascular risk.
* Reimbursed by health insurance

'''Bupropion''' :

* Noradrenaline and dopamine reuptake inhibitor

<br />